A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma, though a stem cell transplant remains the standard of care for relatively younger patients.
http://ift.tt/1A75Len
http://ift.tt/1A75Len
No comments:
Post a Comment